Peter McKenney

Peter McKenney is an Assistant Professor in the Department of Biological Sciences at Binghamton University, where he maintains an active research laboratory focused on microbial pathogenesis and host-microbe interactions. His work primarily investigates the complex relationships between gut microbiota, bacterial pathogens, and host immunity, with particular emphasis on opportunistic pathogens like Clostridioides difficile and Enterococcus faecium.

Dr. McKenney received his educational training through an impressive academic path: he earned his BS from SUNY College at Fredonia, completed his PhD at New York University, and conducted postdoctoral research at Memorial Sloan Kettering Cancer Center. This trajectory has positioned him at the intersection of microbiology, immunology, and infectious disease research.

His research program centers on understanding how the gut microbiota and its small molecule products, particularly bile acids, influence resistance to bacterial pathogens. The McKenney lab investigates the context-dependent continuum between commensalism and pathogenesis, exploring how natural damage suppression mechanisms could provide novel approaches to target bacterial pathogens without traditional antibiotics. A key focus is how antibiotic treatment damages protective gut bacteria and alters immune responses, creating opportunities for pathogens like C. difficile and E. faecium to cause damage. His work has significant implications for understanding and treating antibiotic-associated infections.

Analysis of Dr. McKenney's publication record reveals a cohesive research program spanning microbiology, immunology, and infectious disease. His work consistently explores the role of bile acid metabolism in mediating bacterial morphology, colonization, and host immune responses. A notable pattern across his publications is the investigation of how gut microbiota-derived metabolites influence pathogen behavior and host defense mechanisms. His research bridges fundamental microbial physiology with translational applications for treating antibiotic-resistant infections, particularly those involving C. difficile and vancomycin-resistant Enterococcus.

Dr. McKenney leads the McKenney Lab at Binghamton University, which maintains an active research program investigating fundamental questions in microbial pathogenesis. While specific details about lab members aren't provided in the available information, his research group appears to employ multidisciplinary approaches combining molecular microbiology, host-pathogen interactions, and translational applications. The lab's work addresses critical questions at the interface of microbiology, immunology, and infectious disease, with potential applications for developing novel therapeutic strategies that target pathogen virulence without relying on traditional antibiotics.